Xilio Therapeutics Issues Stock Option Grants to Attract New Talent
Xilio Therapeutics granted stock options for 3,257 shares to two new employees at $8.48 exercise price, reflecting typical equity compensation practices for biotech hiring.
XLOvesting schedulebiotechnology